In another study, low PTEN expression was detected in 57.3% of patients with oral cavity and oropharynx cancers receiving post-operative radiotherapy, with decreased 5-year loco-regional tumor control compared to high PTEN expression (52.3% vs. 80.9%). This evidence concerns the gene PTEN and neoplasm.